FDA grants OCU-300 orphan drug designation for the treatment of ocular graft-versus-host disease Aug. 10, 2017 No Comments
AntriaBio acquires rights to ActiveSite's plasma kallikrein inhibitor program Aug. 8, 2017 No Comments
FDA awards orphan drug designation to Applied Genetic Technologies' gene therapy candidate for XLRP Aug. 4, 2017 No Comments
Aerie collaborates with DSM on technology to deliver compounds for retinal diseases Aug. 1, 2017 No Comments
RSS